PIK3CA and breast carcinoma: For example, the United States Food and Drug Administration (FDA)-approved drugs (Level 1) are available for alterations in ERBB2, PIK3CA for breast cancer and other biomarkers such as MSI-High, TMB-High for all solid tumors.